Doxycycline calcium

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Doxycycline calcium 

Doxycycline calcium 是一种具有口服活性的四环素抗生素，是广谱的金属蛋白酶 (MMP) 抑制剂，具有抗菌活性和抗癌细胞增殖活性。

Doxycycline calcium

Doxycycline calcium Chemical Structure

CAS No. : 94088-85-4

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Doxycycline calcium 的其他形式现货产品:

Doxycycline Doxycycline (hyclate)

生物活性

Doxycycline calcium, an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor[1]. Doxycycline calcium shows antibacterial activity and anti-cancer cell proliferation activity[1][2][3][4][5].

体外研究
(In Vitro)

Doxycycline calcium (0.01-10 µg/mL, 4 d) affects growth of glioma cells only under high concentrations[2].
Doxycycline calcium (0.01-10 µg/mL, 24 h) decreases MT-CO1 protein content with concentrations of 1 µg/mL and higher in SVG cells[2].
Doxycycline calcium (100 ng/mL, 1 µg/mL; 24 h) reduces proliferation of human cell lines[4].
Doxycycline calcium (0-250 μM, 72 h) inhibits cell viability of breast cancer cells [5].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[2]

Cell Line: LNT-229, G55, and U343 glioma cells
Concentration: 0.01, 0.1, 1 or 10 µg/mL
Incubation Time: 4 days
Result: Affected growth of glioma cells only under high concentrations.

Cell Viability Assay[2]

Cell Line: SVG cells
Concentration: 0.01, 0.1, 1 or 10 µg/mL
Incubation Time: 24 hours
Result: Decreaseed MT-CO1 protein content with concentrations of 1 µg/mL and higher.

Cell Proliferation Assay[4]

Cell Line: MCF 12A, 293T cells
Concentration: 100 ng/mL, 1 µg/mL
Incubation Time: 96 hours
Result: Caused reduced proliferation of MCF 12A and 293T cells at 1 µg/mL.

Cell Viability Assay[5]

Cell Line: MCF-7, MDA-MB-468 cells
Concentration: 0-250 μM
Incubation Time: 72 hours
Result: Inhibited breast cancer cells in a dose-dependent manner with IC50 values for MCF-7 and MDA-MB-468 of 11.39 μM and 7.13 μM respectively.

体内研究
(In Vivo)

Doxycycline calcium (oral gavage; 200 or 800 mg/kg; once daily; 3 months) reduces MMP-9 activity in untreated HT mice in a dose-dependent manner[3].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 6-month-old female Heterozygous Col3a1-deficient (HT) mice[3]
Dosage: 200 or 800 mg/kg
Administration: Oral gavage; 200 or 800 mg/kg; once daily; 3 months
Result: Reduced MMP-9 activity in a dose-dependent manner.

分子量

524.59

Formula

C22H24Ca2N2O8
CAS 号

94088-85-4
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Eusebio Manchado, et al. A combinatorial strategy for treating KRAS-mutant lung cancer. Nature. 2016 Jun 30;534(7609):647-51.

    [2]. Anna-Luisa Luger, et al. Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems. Int J Mol Sci. 2018 May 17;19(5):1504.

    [3]. Wilfried Briest, et al. Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome. J Pharmacol Exp Ther. 2011 Jun;337(3):621-7.

    [4]. Ethan Ahler, et al. Doxycycline alters metabolism and proliferation of human cell lines. PLoS One. 2013 May 31;8(5):e64561.

    [5]. Le Zhang, et al. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle. 2017 Apr 18;16(8):737-745.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务